In this interview, we spoke with Grant Swart, VP & General Manager of Mayne Pharma, a leading pharmaceutical company that develops, manufactures, and markets both branded and generic drugs. Grant discusses Mayne Pharma’s commitment to ensuring reliable support for their partners, from Phase I clinical trials through to commercial supply. He also shares the company’s exciting plans for expanding into the European market, bringing their expertise in drug development and manufacturing to new global partnerships.
